Song R, Zeng G, Yu J, Meng X, Chen X, Li J
Emerg Microbes Infect. 2023; 12(1):2212806.
PMID: 37157134
PMC: 10215016.
DOI: 10.1080/22221751.2023.2212806.
Cohen J, Gershon A, Grose C
J Pediatric Infect Dis Soc. 2023; 12(5):262-264.
PMID: 37119057
PMC: 10231346.
DOI: 10.1093/jpids/piad029.
Laing K, Ouwendijk W, Campbell V, McClurkan C, Mortazavi S, Waters M
Nat Commun. 2022; 13(1):6957.
PMID: 36376285
PMC: 9663441.
DOI: 10.1038/s41467-022-34698-4.
Kennedy P, Mogensen T, Cohrs R
Viruses. 2021; 13(10).
PMID: 34696448
PMC: 8540691.
DOI: 10.3390/v13102018.
Gershon A, Gershon M, Shapiro E
J Infect Dis. 2021; 224(12 Suppl 2):S387-S397.
PMID: 34590140
PMC: 8482020.
DOI: 10.1093/infdis/jiaa573.
Safety and Varicella Outcomes in In Utero-Exposed Newborns and Preterm Infants Treated With Varicella Zoster Immune Globulin (VARIZIG): A Subgroup Analysis of an Expanded-Access Program.
Duchon J, Levin M, Gershon A
J Pediatric Infect Dis Soc. 2019; 9(4):449-453.
PMID: 31774916
PMC: 7495903.
DOI: 10.1093/jpids/piz070.
Varicella zoster immune globulin (VARIZIG) administration up to 10 days after varicella exposure in pregnant women, immunocompromised participants, and infants: Varicella outcomes and safety results from a large, open-label, expanded-access program.
Levin M, Duchon J, Swamy G, Gershon A
PLoS One. 2019; 14(7):e0217749.
PMID: 31269033
PMC: 6608934.
DOI: 10.1371/journal.pone.0217749.
Management of varicella in neonates and infants.
Blumental S, Lepage P
BMJ Paediatr Open. 2019; 3(1):e000433.
PMID: 31263790
PMC: 6570487.
DOI: 10.1136/bmjpo-2019-000433.
Varicella Virus Vaccination in the United States.
Shaw J, Gershon A
Viral Immunol. 2017; 31(2):96-103.
PMID: 29173081
PMC: 5863082.
DOI: 10.1089/vim.2017.0136.
Efficacy of varicella (VZV) vaccination: an update for the clinician.
Wang L, Zhu L, Zhu H
Ther Adv Vaccines. 2016; 4(1-2):20-31.
PMID: 27551429
PMC: 4976721.
DOI: 10.1177/2051013616655980.
Zeroing in on zoster: A tale of many disorders produced by one virus.
Galetta K, Gilden D
J Neurol Sci. 2015; 358(1-2):38-45.
PMID: 26454371
PMC: 4628852.
DOI: 10.1016/j.jns.2015.10.004.
Abortive intrabronchial infection of rhesus macaques with varicella-zoster virus provides partial protection against simian varicella virus challenge.
Meyer C, Engelmann F, Arnold N, Krah D, Ter Meulen J, Haberthur K
J Virol. 2014; 89(3):1781-93.
PMID: 25410871
PMC: 4300754.
DOI: 10.1128/JVI.03124-14.
Updated recommendations for use of VariZIG--United States, 2013.
MMWR Morb Mortal Wkly Rep. 2013; 62(28):574-6.
PMID: 23863705
PMC: 4604813.
CD4 T cell immunity is critical for the control of simian varicella virus infection in a nonhuman primate model of VZV infection.
Haberthur K, Engelmann F, Park B, Barron A, Legasse A, Dewane J
PLoS Pathog. 2011; 7(11):e1002367.
PMID: 22102814
PMC: 3213099.
DOI: 10.1371/journal.ppat.1002367.
Varicella-zoster virus (chickenpox) infection in pregnancy.
Lamont R, Sobel J, Carrington D, Mazaki-Tovi S, Kusanovic J, Vaisbuch E
BJOG. 2011; 118(10):1155-62.
PMID: 21585641
PMC: 3155623.
DOI: 10.1111/j.1471-0528.2011.02983.x.
Zoster vaccine recommendations: the importance of using a clinically valid correlate of protection.
Oxman M, Gershon A, Poland G
Vaccine. 2011; 29(20):3625-7.
PMID: 21524565
PMC: 5381800.
DOI: 10.1016/j.vaccine.2011.04.019.
Congenital varicella syndrome: the evidence for secondary prevention with varicella-zoster immune globulin.
Cohen A, Moschopoulos P, Maschopoulos P, Stiehm R, Koren G
CMAJ. 2011; 183(2):204-8.
PMID: 21262937
PMC: 3033924.
DOI: 10.1503/cmaj.100615.
Chickenpox.
Swingler G
BMJ Clin Evid. 2009; 2007.
PMID: 19454112
PMC: 2943770.
Zoster Immune Globulin (ZIG).
Chin J
Calif Med. 1973; 118(5):58-9.
PMID: 18730939
PMC: 1455047.
Zoster immune globulin for chickenpox prevention.
Tompkins R
Calif Med. 1970; 112(3):61.
PMID: 18730279
PMC: 1501393.
